OraSure Technologies, Inc. Announces Purchase of UrSure, Inc.

OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection and stabilization devices, and microbiome laboratory and analytical services, today announced that it has entered into a definitive agreement to acquire privately owned UrSure, Inc. (“UrSure”) for cash. Based in Boston, UrSure is developing and commercializing products that measure adherence to HIV medications including pre-exposure prophylaxis or PrEP, the daily medication to prevent HIV. This includes laboratory-based tests that can measure levels of the medication in a patient’s urine or blood, as well as several additional point of care products in development. These products will allow healthcare professionals to assess patient adherence and determine with accuracy if the medication has not been taken as prescribed. PrEP has been shown to be 99 percent effective at preventing HIV infection when taken daily, adding another tool to help ensure that patients stay healthy.

Read the full article: OraSure Technologies, Inc. Announces Purchase of UrSure, Inc. //

Source: https://www.globenewswire.com/news-release/2020/05/29/2040821/0/en/OraSure-Technologies-Inc-Announces-Purchase-of-UrSure-Inc.html

Scroll to Top